STERIS plc

STE Healthcare Medical Devices

STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025.

Revenue
+8.79%
EPS
+12.8%
Free cash flow
+43.6%
Total debt
−0.21%

Quarter to September 2026, against a year earlier

252.70 1.42 −0.56%
Market cap
$24.8B
P/E
30.0×
Fwd P/E
25.1×
Dividend yield
1.02%
F-score
9/9
Altman Z
5.10
Beneish M
−2.68
Dividend safety
86/100
Older periods Dec '25 Mar '26 Jun '26 Sep '26 From the 10-Q filed 5 Nov
P/E ratio

+8 more quarters

35.26 27.78 25.65 24.82
P/S ratio
4.27 3.66 3.40 3.31
P/FCF ratio
26.58 22.09 21.96 21.80
P/Operating CF
83.49 64.74 55.98 70.71
P/B ratio
3.47 3.02 2.85 2.81
EV/Sales
4.55 3.91 3.64 3.54
EV/EBITDA
17.82 14.61 13.45 13.09
EV/FCF
28.29 23.61 23.46 23.26
Current Ratio
2.48 2.09 1.91 2.05
Net Debt/EBITDA
3.73 3.39 3.44 3.24
Debt/Equity
0.26 0.27 0.26 0.26
Earnings Yield
2.84% 3.60% 3.90% 4.03%
Free Cash Flow Yield
3.76% 4.53% 4.55% 4.59%
Free Cash Flow per Share
2.14 2.50 2.86 2.97
Book value per Share
72.99 73.29 73.99 74.73
Free Cash Flow
209.90 245.30 279.60 289.00
EV/EBIT
26.46 21.06 19.24 18.63
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026